NYSE:ARE
NYSE:AREHealth Care REITs

A Look At Alexandria Real Estate Equities (ARE) Valuation After Large Impairments And Dividend Cut

Alexandria Real Estate Equities (ARE) is back in focus after reporting a Q4 2025 net loss of about US$1.1b and a full year loss of roughly US$1.4b, which the company attributed largely to real estate impairments. See our latest analysis for Alexandria Real Estate Equities. That earnings release and the fresh US$800m tender offer for long dated notes come after a volatile stretch, with a 1 month share price return of 9.26% but a 1 year total shareholder return of 39.97% in the red. This...
NYSE:MPLX
NYSE:MPLXOil and Gas

Is MPLX (MPLX) Still Attractively Priced After Its Recent Strong Share Price Run?

If you are wondering whether MPLX is still reasonably priced after its strong run, this article will help you make sense of where the current share price sits against different views of value. With the stock at US$56.24 and returns of 1.2% over 7 days, 4.8% over 30 days, 4.4% year to date and 13.9% over 1 year, many investors are asking whether the recent performance reflects growth potential or a shift in perceived risk. Over the past few months, MPLX has attracted attention as investors...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

Gold Royalty (GROY) Valuation After Borborema Royalty Deal And Record Preliminary Revenue

Gold Royalty (GROY) has been in focus after reporting preliminary revenue of US$4,501,000 for the quarter and US$15,610,000 for 2025, alongside acquiring a net smelter royalty on Brazil’s Borborema gold mine. See our latest analysis for Gold Royalty. At a share price of US$4.65, Gold Royalty has seen a 26.02% 90 day share price return and a very large 263.28% 1 year total shareholder return. This suggests recent momentum that contrasts with the 1 day and 7 day pullback, as the market weighs...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Trimble’s New Midwest Outlet Partnership And What It Means For Valuation

Trimble (NasdaqGS:TRMB) has appointed West Side Tractor Sales Co. as its newest Trimble Technology Outlet. The partnership focuses on civil construction customers using John Deere earthmoving equipment. The agreement covers northern Illinois, Indiana, and parts of Michigan. Customers in these territories gain broader access to Trimble grade control and site positioning solutions. For you as an investor looking at Trimble, this move fits within its core role providing technology for civil...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Why Intellia Therapeutics (NTLA) Is Down 12.6% After FDA Lifts Hold On Key CRISPR Trial

In late January 2026, Intellia Therapeutics announced that the FDA removed the clinical hold on its MAGNITUDE-2 Phase 3 trial of CRISPR-based therapy nexiguran ziclumeran for hereditary transthyretin amyloidosis with polyneuropathy, allowing patient enrollment and dosing to resume under enhanced liver safety monitoring and a slightly expanded enrollment target. This decision marks a key regulatory step for Intellia’s in vivo gene-editing program, highlighting both the promise of a one-time...
NYSE:NEM
NYSE:NEMMetals and Mining

How Investors Are Reacting To Newmont (NEM) Surging With Record Gold Prices And Portfolio Streamlining

In late January 2026, Newmont benefited from record-breaking gold and silver prices driven by geopolitical tensions, economic uncertainty, and strong central bank demand, alongside fresh operational updates at the AME Roundup conference in Vancouver. Together with streamlining after the Newcrest acquisition and plans to sell millions of ounces from core mines, these conditions have sharpened Newmont’s role as a key proxy for safe-haven precious metals exposure. We’ll now examine how this mix...
NYSE:SE
NYSE:SEMultiline Retail

Sea Prioritizes Growth Investments As Valuation Signals Potential Upside

Sea Limited (NYSE:SE) recently reported quarterly results that highlighted strong revenue and gross merchandise value performance. Management chose to prioritize growth initiatives in logistics, fulfillment, and membership programs, even though these moves weigh on near term margins. The company signaled an intention to keep funding these initiatives as it refines its business model and competitive position. Sea runs a broad digital ecosystem across e commerce, digital entertainment, and...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly Extends Beyond GLP 1 With Gene Editing And Cancer Push

Eli Lilly (NYSE:LLY) agreed to work with Seamless Therapeutics on gene editing therapies for hearing loss. The company entered a research agreement with Repertoire Immune Medicines to pursue tolerizing therapies for autoimmune diseases. The FDA granted Breakthrough Therapy designation to oncology candidate sofetabart mipitecan for platinum resistant ovarian cancer. Eli Lilly, long known for its diabetes and obesity franchises, is pushing further into genetic medicines and oncology as it...